Enanta Pharmaceuticals reported $1.48M in Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Abbvie ABBV:US $ 85530M 526M
Acorda Therapeutics ACOR:US $ 236.9M 2.1M
Amgen AMGN:US $ 32685M 301M
Anika Therapeutics ANIK:US $ 0.12M 0.03M
Arrowhead Research ARWR:US $ 0M 0M
AstraZeneca AZN:LN 27495M 7363M
Biocryst Pharmaceuticals BCRX:US $ 30M 244.45M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Clovis Oncology CLVS:US $ 64.28M 545.69M
Enanta Pharmaceuticals ENTA:US $ 1.48M 0M
GlaxoSmithKline GSK:LN 25483M 736M
Halozyme Therapeutics HALO:US $ 873.77M 476.54M
Heron Therapeutics HRTX:US $ 7.56M 0.5M
Insmed INSM:US $ 377.11M 5M
Karyopharm Therapeutics KPTI:US $ 241.79M 50.78M
Ligand Pharmaceuticals LGND:US $ 0.04M 357.7M
Neurocrine Biosciences NBIX:US $ 322M 4.1M
Novartis NOVN:VX SF 37799M 250M
Novavax NVAX:US $ 460.23M 7.75M
Ptc Therapeutics PTCT:US $ 46.46M 1100.31M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Vertex Pharmaceuticals VRTX:US $ 569.75M 39.42M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 34.47M 0.39M